麦克森公司

MCK represents McKesson Corporation, a U.S.-based healthcare distribution and services company. It supplies pharmaceuticals, medical supplies, and healthcare information technology to providers such as hospitals, pharmacies, and clinics. McKesson is one of the largest distributors in the healthcare supply chain, with operations primarily in the United States and Canada. Its business model focuses on distribution logistics and related services rather than manufacturing drugs.

Recent performance of MCK stock can be seen in the price chart and percentage changes displayed on this page. Those figures update regularly, so they reflect the latest available market data. For context, compare the current price to the 52-week range and major moving averages shown. Performance over different periods, such as one month or one year, is also typically listed in the stock summary section.

Evaluating MCK's valuation involves comparing its current price to metrics like the price-to-earnings (P/E) ratio, price-to-sales, and enterprise value-to-EBITDA. These are available on this page and can be benchmarked against peers in the healthcare distribution industry. Since valuation depends on earnings growth, margins, and debt levels, review MCK's financial statements and recent performance alongside these ratios to form a balanced view.

MCK stock can often be traded in pre-market and after-hours sessions through many brokerages, though liquidity is usually lower and spreads may be wider than during regular trading. Overnight trading is also available on some platforms. The hours and availability depend on your broker. Check the trading section of this page for any exchange-specific details or session times related to MCK.

McKesson Corporation pays a regular quarterly dividend, which is reflected in the dividend information on this page. The current amount per share, yield, and payment schedule are shown there and update with company announcements. Investors often review the payout ratio and dividend history to assess sustainability. Any changes to the dividend policy would be announced by the company and reflected in that data.

Key risks for MCK include regulatory changes in drug pricing and healthcare reimbursement, customer concentration among large pharmacy chains, and supply chain disruptions. The company also faces competition from other distributors and potential legal or compliance issues. Economic downturns can affect prescription volumes, while interest rate changes may influence borrowing costs. These factors, among others, are detailed in McKesson's SEC filings.